WHO vaccine-preventable diseases: monitoring system. 2020 global summary

Last updated 15-July-2020 (data as of 12-October-2020)
Next overall update End 2020
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'8601 Infant (under 12 months) mortality rate: 212
GDP / capita (US$): 14'4281 Child (under 5 years) mortality rate: 252

Population data in thousands3

  2019  2018  2017  2016  2015  2000  1990  1980 
Total population 890  883  877  872  869  811  729  635 
Births 19  19  19  19  19  20  21  22 
Surviving infants 18  18  19  19  19  20  21  21 
Pop. less than 5 years 90  91  91  92  94  98  100  92 
Pop. less than 15 years 261  261  260  259  259  284  280  249 
Female 15-49 years 227  226  226  225  224  208  184  161 

Number of reported cases

(Click for retrospective incidence data for Fiji)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles***
ChartChart
  28  32  913 
Mumps
ChartChart
 
Pertussis
ChartChart
  13 
Polio*
ChartChart
 
Rubella***
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.
*** For 2019, if a country did not submit a joint reporting form, measles and rubella cases were sourced from data reported through the monthly surveillance data available from:
https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Fiji)
Vaccine year result method % card seen                                                
BCG 2011  99  EPI   95  97  76  99*  99  99  99*  95 
DTP1 2011  99  EPI   95  92  89  99  95  98 
DTP3 2011  98  EPI   95  91  85  98  93  96  82  68 
IPV1          91  86  82  93 
HepB_BD          77  99*  95  99 
HepB3 2011  98  EPI   95  85  98  93  94 
Hib3 2011  98  EPI   95  85  98  93  94 
JapEnc         
MCV1          83  81  96  95  95  72  32 
MCV2          72  95  99*  95  99* 
MenA         
PCV1          92  89  84  95  98 
PCV2          90  87  82  93  94 
PCV3          91  86  82  93  94 
Pol3 2011  98  EPI   95  86  98  93  94  87  55 
Rota1          92  90  84  95  98 
RotaC          91  86  82  93  94 
RCV1          83  81  88  95  95 
TT2plus 2012  46  EPI   95  41  72  51  95  64 
PAB          73  46  90 
VAD1          10 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2021

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Fiji)
BCG
ChartChart
  99  99  99  99  99  96  99  95 
DTP1
ChartChart
  99  99  99  99  99  97  98  87 
DTP3
ChartChart
  99  99  99  99  99  90  97  68 
HepB3
ChartChart
  99  99  99  99  99  98 
HepB_BD
ChartChart
  99  99  99  99  99 
Hib3
ChartChart
  99  99  99  99  99  98 
IPV1
ChartChart
  99  99  99  99 
MCV1
ChartChart
  96  96  96  96  96  81  84  32 
MCV2
ChartChart
  94  94  94  94  94 
PCV3
ChartChart
  99  99  99  99  99 
Pol3
ChartChart
  99  99  99  99  99  91  96  55 
RCV1
ChartChart
  96  96  96  96  96  81 
RotaC
ChartChart
  99  99  99  99  99 

Click to download WHO-UNICEF coverage estimates data for PAB time series.
Click to download WHO-UNICEF coverage estimates data for HPV time series.

Number of districts in the country 19  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2019 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes and catch-up until 12 months
DTwPHibHepB 6, 10, 14 weeks; Yes and catch-up until 8 years
HepB_Adult 1st contact; +6, +14 weeks; Yes medical, nursing students, all healthcare workers
HepB_Pediatric birth; Yes and pre-term babies are "special" booster at 12 months with MR1
HPV 8-13 years; +6 months; Yes females; class 8
IPV 14 weeks; Yes and any age when vaccination is required
MR 12, 18 months; 6 years; Yes
OPV 6, 10, 14 weeks; 18 months; Yes and at any age when vaccination is required
Pneumo_conj 6, 10, 14 weeks; Yes and catch-up until 2 years
Rotavirus 6, 14 weeks; Yes and catch-up until 2 years
Td 6, 11 years; Yes school children in year 1 and 6, and pregnant mothers
VitaminA 6, 12, 18, 30, 36, 42 months; Yes adminstered every 6 months until 5 years

Immunization indicators

Indicator Expected answer 2019  2018  2017  2016  2015  2014  2013 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  Yes  Yes  Yes 
What years does the MYP cover? number         2013-2015  2013-2015   

System performance

Total Nº districts in country number 19  19  19  19  19  19  19 
Nº districts with DTP3 coverage >=80% number   19    19  19  19   
% of districts with DTP3 coverage >=80% From 0 to 100%   100    100  100  100   
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%       89  100    100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes    No  Yes  Yes  Yes  Yes 

Sources

 1  "The 2019 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  UN Inter-agency Group for Child Mortality Estimation (https://childmortality.org/data)  
 3  "United Nations, Population Division. The World Population Prospects - the 2019 revision". New York, 2019.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.